Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Valeant_Pharmaceuticals'_Asia-Pacific_operations
|
| gptkbp:CEO |
gptkb:Dan_Spira
|
| gptkbp:founded |
1937
|
| gptkbp:headquartersLocation |
gptkb:Sydney,_Australia
|
| https://www.w3.org/2000/01/rdf-schema#label |
iNova Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Betadine
gptkb:Difflam gptkb:Duro-Tuss gptkb:Duromine gptkb:Ferrograd |
| gptkbp:parentCompany |
gptkb:The_Carlyle_Group
gptkb:Pacific_Equity_Partners |
| gptkbp:products |
over-the-counter medicines
prescription medicines |
| gptkbp:servesArea |
gptkb:Africa
gptkb:Middle_East gptkb:Asia-Pacific |
| gptkbp:website |
https://www.inovapharma.com/
|
| gptkbp:bfsParent |
gptkb:Valeant_Pharmaceuticals
|
| gptkbp:bfsLayer |
6
|